ARCHIVES

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

Centers Form Big Ten Research Consortium with Access to Over 30,000 New Patients a Year

May 31, 2013

NCCS Networker Volume 6 Issue 1, Winter 1992

January 13, 1992

NCI Bioinformatics After Kenneth Buetow: Varmus Launches Fundamental Redesign

January 6, 2012

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005

Bypass Budget Is Realistic, Defensible Plan, Broder Says

September 27, 1991